首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of pharmaceutical health care and sciences

缩写:

ISSN:2055-0294

e-ISSN:2055-0294

IF/分区:1.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引577
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yamato Kato,Ryogo Umetsu,Junko Abe et al. Yamato Kato et al.
Background: Antipsychotics are potent dopamine antagonists used to treat schizophrenia and bipolar disorder. The aim of this study was to evaluate the relationship between antipsychotic drugs and adverse hyperglycemic eve...
Masayuki Hashiguchi,Yuriko Ohta,Mikiko Shimizu et al. Masayuki Hashiguchi et al.
Background: The benefit of Ginkgo biloba for the treatment of dementia remains controversial. The aim of this study was to evaluate the efficacy and safety of Ginkgo biloba in patients with dementia in whom administration...
Elias Packman,Rina Leyva,David Kellstein Elias Packman
Background: Ibuprofen is known to be efficacious in the treatment of tension-type headache, the most common form of primary headache. A novel tablet formulation of ibuprofen sodium is more rapidly absorbed than standard i...
Yasunari Mano,Shota Fukushima,Hisayuki Kuroda et al. Yasunari Mano et al.
Background: Effect of statin therapy has been reported to be associated with patient's adherence. Atorvastatin was available in Japan as a brand-name product beginning in 2000. The first atorvastatin generics were introdu...
Toshikazu Tsuji,Toshihiro Irisa,Shunichi Ohata et al. Toshikazu Tsuji et al.
Background: There are many reports regarding various medical institutions' attempts at incident prevention, but the relationship between incident types and impact on patients in drug name errors has not been studied. Ther...
Makoto Hayashi,Akimasa Yamatani,Hiromu Funaki et al. Makoto Hayashi et al.
Background: It is important for pharmacists to manage cancer chemotherapy regimens in order to achieve safe treatment. We examined whether there was a useful pharmacoeconomic benefit of compliance the exclusion criteria o...
Yoshinori Onuki,Naoki Hasegawa,Chihiro Kida et al. Yoshinori Onuki et al.
Background: Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different con...
Yasuko Kurata,Narumi Miyauchi,Manabu Suno et al. Yasuko Kurata et al.
Background: Crizotinib, an ATP-competitive receptor tyrosine kinase inhibitor of both anaplastic lymphoma kinase (ALK) and the hepatocyte growth factor receptor, commonly causes several adverse events (AEs). The clinical ...
Masako Hashimoto,Kanako Hashimoto,Fumihiko Ando et al. Masako Hashimoto et al.
Background: The lower urinary tract symptoms (LUTS) increases with age and can have a significant effect on the quality of life of the patients. Elderly patients, who are often characterized by a decline in physiological ...
Makoto Kajizono,Megumu Aoyagi,Yoshihisa Kitamura et al. Makoto Kajizono et al.
Background: It is well known that molecular-targeted drugs, of which sorafenib (Nexavar®) is one, differ from previous anticancer drugs and cause various unusual adverse drug reactions. Treatment with sorafenib causes ad...